These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31605161)
1. [Revised S3 guidelines on schizophrenia : Developmental process and selected recommendations]. Hasan A; Falkai P; Lehmann I; Janssen B; Wobrock T; Zielasek J; Gaebel W Nervenarzt; 2020 Jan; 91(1):26-33. PubMed ID: 31605161 [TBL] [Abstract][Full Text] [Related]
2. [National and international schizophrenia guidelines. Update 2013 regarding recommendations about antipsychotic pharmacotherapy]. Hasan A; Wobrock T; Gaebel W; Janssen B; Zielasek J; Falkai P; ; Nervenarzt; 2013 Nov; 84(11):1359-60, 1362-4, 1366-8. PubMed ID: 24077969 [TBL] [Abstract][Full Text] [Related]
3. [Psychosocial therapy in psychiatry : Update of the DGPPN-S3 guidelines "Psychosocial therapies for severe mental illnesses"]. Gühne U; Weinmann S; Becker T; Riedel-Heller SG Nervenarzt; 2020 Nov; 91(11):993-1002. PubMed ID: 32725490 [TBL] [Abstract][Full Text] [Related]
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
5. [Diseases of the schizophrenia spectrum disorder in old age : Diagnostic and therapeutic challenges]. Jagsch C; Hofer A Z Gerontol Geriatr; 2018 Nov; 51(7):744-750. PubMed ID: 30109423 [TBL] [Abstract][Full Text] [Related]
7. [Early recognition and prevention of schizophrenia and other psychoses]. Meisenzahl E; Walger P; Schmidt SJ; Koutsouleris N; Schultze-Lutter F Nervenarzt; 2020 Jan; 91(1):10-17. PubMed ID: 31858162 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and therapeutic guidelines (algorithms) in the treatment of schizophrenia. Recommendations of the Croatian Society for Clinical Psychiatry of the Croatian Medical Association]. Strkalj Ivezić SS; Smalc VF; Mimica N; Bjegović MB; Makarić G; Bagarić A; Krpan I; Lijec Vjesn; 2001; 123(11-12):287-92. PubMed ID: 11930753 [TBL] [Abstract][Full Text] [Related]
9. [Health Care Organization - The New German S3-Guideline on Alcohol-Related Disorders and its Relevance for Health Care]. Günthner A; Weissinger V; Fleischmann H; Veltrup C; Jäpel B; Längle G; Amann K; Hoch E; Mann K Rehabilitation (Stuttg); 2018 Oct; 57(5):314-320. PubMed ID: 29359282 [TBL] [Abstract][Full Text] [Related]
13. [Methodology of the S3 guidelines on alcohol and tobacco-related disorders]. Hoch E; Petersen K; Kopp I; Batra A; Mann K Nervenarzt; 2016 Jan; 87(1):6-12. PubMed ID: 26678625 [TBL] [Abstract][Full Text] [Related]
14. [Psychosocial therapies in severe mental illness: DGPPN-S3-guideline: evidence, recommendations and challenges for mental health service research]. Riedel-Heller SG; Gühne U; Weinmann S; Becker T; Psychother Psychosom Med Psychol; 2012 Nov; 62(11):425-8. PubMed ID: 23143829 [TBL] [Abstract][Full Text] [Related]
15. Sports Therapy for Schizophrenia Psychoses: from the Idea to the Guideline. Falkai P; Schwaiger R; Schmitt A; Röll L; Maurus I Gesundheitswesen; 2023 Sep; 85(S 03):S212-S217. PubMed ID: 37751760 [TBL] [Abstract][Full Text] [Related]
16. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]. Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464 [TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany. Zeidler J; Mahlich J; Greiner W; Heres S Appl Health Econ Health Policy; 2013 Oct; 11(5):509-21. PubMed ID: 23975630 [TBL] [Abstract][Full Text] [Related]
18. [Participation is the foundation of successful treatment of psychotic disorders]. Flyckt L; Msghina M Lakartidningen; 2015 Oct; 112():. PubMed ID: 26461500 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France]. Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P Encephale; 2017 Aug; 43(4):311-320. PubMed ID: 27623123 [TBL] [Abstract][Full Text] [Related]
20. Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines. Preuss UW; Gouzoulis-Mayfrank E; Havemann-Reinecke U; Schäfer I; Beutel M; Hoch E; Mann KF Eur Arch Psychiatry Clin Neurosci; 2018 Apr; 268(3):219-229. PubMed ID: 28439723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]